Biggest News Aggregation in the World
๐Ÿ“ฐ Intel Corp News

Page 33 - Intel Corp News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Intel Corp. Real-time updates on events, politics, business and more.

EFFECTOR Reports Results Of Phase2 KICKSTART Trial Of Tomivosertib-Pembrolizumab In NSCLC

EFFECTOR Therapeutics, Inc. (EFTR) announced Thursday topline results from the primary analysis of the randomized Phase 2 KICKSTART trial which tested tomivosertib or placebo, each combined with pembrolizumab, as frontline treatment for patients with non-small cell lung cancer (NSCLC) with PD-L1 =50%.
Basel Stadt United States City Of United Kingdom T Inc Intel Corp

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science